Projects

National

• Genetic causes of rare inherited metabolic diseases with emphasis on functional studies of novel variants
  Program: SRDA
  Duration: 1. 7. 2023 – 30. 6. 2027

• Mitochondrial disease in heart failure
  Program: SRDA
  Duration: 1. 7. 2022 – 30. 6. 2026

• Mutations associated with Wolfram syndrome: alternative signaling pathways for calcium and mitochondrial physiology
  Program: SRDA
  Duration: 1. 7. 2022 – 30. 6. 2026

• Suicide gene therapy mediated by mesenchymal stromal and pancreatic tumor cell-excreted extracellular vesicles in the treatment of pancreatic ductal adenocarcinoma
  Program: SRDA
  Duration: 1. 7. 2021 – 30. 6. 2025

• Dyad remodelling in cardiomyocytes in experimental therapy of failing heart
  Program: VEGA
  Duration: 1. 1. 2021 – 31. 12. 2024

• Dominant mutations in Wolfram syndrome: different mechanism to the recessive ones?
  Program: VEGA
  Duration: 1. 1. 2019 – 31. 12. 2022

• Mechanisms of skeletal muscle adaptation to regular exercise in patients with chronic metabolic and inflammatory disease
  Program: VEGA
  Duration: 1. 1. 2019 – 31. 12. 2022

• Mitochondrial dynamics and morphology in transgenic model of Wolfram syndrome: emerging role for heart protection
  Program: VEGA
  Duration: 1. 1. 2016 – 31. 12. 2018